How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Toxicological Services Market
- By Service Type: In vitro Toxicology Testing, In vivo Toxicology Testing, Computational Toxicology, Analytical Toxicology, Genotoxicity Testing, Ecotoxicology Testing
- By End-Use Industry: Pharmaceuticals, Biotechnology, Chemical Industry, Food and Beverage, Cosmetics and Personal Care, Agriculture
- By Test Type: Acute Toxicity Testing, Chronic Toxicity Testing, Carcinogenicity Testing, Reproductive and Developmental Toxicity Testing, Neurotoxicity Testing, Immunotoxicity Testing
- By Test Model: Rodent Models, Non-Rodent Models, Cell Lines, 3D Tissue Models, Microbial Models
- By Service Provider: Contract Research Organizations (CROs), Academic and Research Institutions, In-house Toxicology Departments, Government Toxicology Laboratories
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - In vitro Toxicology Testing leads By Service Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 17 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 315 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.187 →
- 12 Company Profiles 17 players: SWOT & benchmarking p.195 →
Full report · locked preview
Everything inside the Toxicological Services Market report
A complete, evidence-based study - 12 chapters and 132 sections covering market size, segmentation across 5 axes, regional analysis and 17 company profiles, forecast to 2033.
Segmentation covered
Service Type 6
End-Use Industry 6
Test Type 6
Test Model 5
Service Provider 4
Companies profiled
Charles River Laboratories International Inc.
Covance Inc. (LabCorp)
Eurofins Scientific
ICON plc
PRA Health Sciences (now part of ICON plc)
WuXi AppTec
Envigo (now part of Labcorp)
QPS Holdings
LLC
Toxikon Corporation
NAMSA
BioReliance (a MilliporeSigma company)
+5 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
17 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Charles River Laboratories International Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Covance Inc. (LabCorp)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Eurofins Scientific
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →ICON plc
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →PRA Health Sciences (now part of ICON plc)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →WuXi AppTec
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Envigo (now part of Labcorp)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →QPS Holdings
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →LLC
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Toxikon Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →NAMSA
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →BioReliance (a MilliporeSigma company)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Frontage Laboratories Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.227 →MPI Research (now part of Charles River Laboratories)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Pharmaron
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →ToxPath
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.250 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$10,196M by 2033 · 9.0% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- In vitro Toxicology Testing39.1
- In vivo Toxicology Testing13.3
- Computational Toxicology14.6
- Analytical Toxicology10.6
- Genotoxicity Testing7.8
- Ecotoxicology Testing14.5
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,693M → $3,643M · 10.1%
Europe$1,180M → $2,128M · 7.6%
Asia Pacific$1,078M → $2,402M · 10.5%
Latin America$667.0M → $1,362M · 9.3%
Middle East and Africa$513.1M → $1,108M · 10.1%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →8.922026
8.932027
8.942028
8.952029
8.972030
8.972031
8.992032
9.002033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Charles River Laboratories International Inc.17.3
- Covance Inc. (LabCorp)20.0
- Eurofins Scientific9.5
- ICON plc9.0
- PRA Health Sciences (now part of ICON plc)11.5
- WuXi AppTec4.7
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Service Type27.6%
End-Use Industry16.8%
Test Type12.1%
Test Model28.6%
Service Provider14.9%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America34.2
- Europe20.0
- Asia Pacific22.6
- Latin America12.8
- Middle East and Africa10.4
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Charles River Laboratories International Inc. | 82 | 78 | 91 | 88 | 80 | 78 | 83 |
| Covance Inc. (LabCorp) | 88 | 76 | 89 | 81 | 75 | 90 | 83 |
| Eurofins Scientific | 87 | 73 | 68 | 87 | 65 | 79 | 77 |
| ICON plc | 71 | 61 | 59 | 77 | 70 | 59 | 66 |
| PRA Health Sciences (now part of ICON plc) | 61 | 55 | 69 | 72 | 61 | 57 | 63 |
| WuXi AppTec | 57 | 52 | 46 | 67 | 54 | 50 | 54 |
| Envigo (now part of Labcorp) | 51 | 65 | 65 | 55 | 44 | 65 | 58 |
| QPS Holdings | 39 | 54 | 53 | 41 | 37 | 54 | 46 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Charles River Laboratories International Inc.
- Covance Inc. (LabCorp)
- Eurofins Scientific
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Charles River Laboratories International Inc. | ◐ | ◐ | ◐ | ✓ | ✓ | ◐ |
| Covance Inc. (LabCorp) | ✓ | ◐ | ✓ | ✓ | ◐ | ◐ |
| Eurofins Scientific | ◐ | − | ◐ | ✓ | − | ◐ |
| ICON plc | ✓ | ◐ | − | ◐ | ◐ | ◐ |
| PRA Health Sciences (now part of ICON plc) | − | ◐ | ◐ | ◐ | ◐ | ◐ |
| WuXi AppTec | ◐ | − | − | − | ◐ | − |
| Envigo (now part of Labcorp) | − | ◐ | ◐ | ◐ | − | ◐ |
| QPS Holdings | − | ◐ | ◐ | ◐ | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Charles River Laboratories International Inc.83
2Covance Inc. (LabCorp)83
3Eurofins Scientific77
4ICON plc66
5PRA Health Sciences (now part of ICON plc)63
6Envigo (now part of Labcorp)58
7WuXi AppTec54
8QPS Holdings46
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Charles River Laboratories International Inc.Covance Inc. (LabCorp)
Challenger1
Strong scale, closing on the leaders.
Eurofins Scientific
Contender3
Focused players with pockets of strength.
ICON plcPRA Health Sciences (now part of ICON plc)Envigo (now part of Labcorp)
Niche2
Specialists in a single segment or region.
WuXi AppTecQPS Holdings
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Service Type in North America, then scale across Toxicological Services Market — a $118M beachhead inside a $1.90B market.
Beachhead (SOM)$118Mobtainable near-term
Serviceable (SAM)$739Mreachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion91 fit
In vitro Toxicology Testing
Best fit — highest urgency & budget in Service Type.
Economic buyer81 fit
In vivo Toxicology Testing
Strong fit — clear ROI and a fast path to value.
End user64 fit
Computational Toxicology
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Service Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add End-Use Industry & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Test Type
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales44%
Partner / channel29%
Digital / self-serve20%
Marketplaces6%
Positioning & messaging
§GTM 2 · p.194 →For Service Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Toxicological Services Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified40%
Sales qualified23%
Evaluation12%
Closed-won8%
$8.3KCAC
$45KLTV
5.4:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Toxicological Services Market is a resilient opportunity — $7.01B by 2033, compounding at 5.8%.
TAM · 2025$4.45Btoday
TAM · 2033$7.01Bforecast
CAGR5.8%2027–2033
Cumulative$50.8Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$7.01BTotal addressable market
SAM$2.43BServiceable available market
SOM$479MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →5.8% CAGR
Demand compounds through 2033, outpacing GDP across Service Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Service Type moving from early to mainstream — durable secular demand.
Consolidation upside
17+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$7.01BLarge & growingTAM by 2033 at 5.8% CAGR
$2.43BServiceable nowreachable with today’s model
$479MBeachhead winobtainable near-term share
17+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$5.46BBear3.8% CAGR
$7.01BBase5.8% CAGR
$8.97BBull7.7% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & End-Use Industry optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Toxicological Services Market — a $11.0B market by 2033. Plan: grow share from 6.1% to 11.6%.
Market size · 2033$11.0Btotal addressable
Market CAGR11.7%2027–2033
Target share11.6%from 6.1% today
Revenue ambition$1.28Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 6.1% | 11.6% | On track |
| Revenue | $628M | $1.28B | Behind |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Behind |
| Gross margin | 35.0% | 45.1% | At risk |
| Customer retention | 90.4% | 92.4% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Service Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build End-Use Industry capability
A defensible second engine — invest in End-Use Industry to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Service Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch End-Use Industry
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $185M capacity & capability investment
- Greenlight bolt-on M&A in End-Use Industry
- Authorise North America expansion plan
- Fund R&D program for Service Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownBehind
- Competitive share lossAt risk
- Input-cost & supply riskBehind
- Regulatory / policy changeAt risk
- Execution & talentAt risk
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Toxicological Services Market conversation — a $5.90B market you can size, segment and defend in minutes.
Market size · 2033$5.90Btotal opportunity
Growth5.8%CAGR to 2033
Addressable buyers1,264+accounts in scope
Typical ROI4.7×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Service Type
Goal Grow share in Service Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.7×return on cost, year one
< 3 mopayback period
$95K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
17+players profiled in this market
Coverage includes
Charles River Laboratories International Inc.Covance Inc. (LabCorp)Eurofins ScientificICON plcPRA Health Sciences (now part of ICON plc)WuXi AppTecEnvigo (now part of Labcorp)QPS Holdings+9 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Toxicological Services Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Toxicological Services Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Toxicity Testing Outsourcing Market
Market size, share, segmentation and regional forecast.
$2.1B market · 2025 base year
View reportToxicity Luminometer Market
Market size, share, segmentation and regional forecast.
$1.1B market · 2025 base year
View reportToxic Epidermal Neurolysis Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportToxic Epidermal Neurolysis Drug Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportToxic Epidermal Necrolysis (TEN) Market
Market size, share, segmentation and regional forecast.
$4.1B market · 2025 base year
View reportTourniquet Devices Market
Market size, share, segmentation and regional forecast.
$3.8B market · 2025 base year
View reportTourette Syndrome Treatment Market
Market size, share, segmentation and regional forecast.
$2.4B market · 2025 base year
View reportTouch Screen RF Ablation System Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View reportTouch Screen Patient Infotainment Terminal Market
Market size, share, segmentation and regional forecast.
$3.3B market · 2025 base year
View reportTouch Screen Patient Bedside Terminal Market
Market size, share, segmentation and regional forecast.
$305M market · 2025 base year
View reportTouch-screen Dry Block Temperature Calibrators Market
Market size, share, segmentation and regional forecast.
$4.8B market · 2025 base year
View reportTouch Screen Dry Bath Incubator Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.